“Reply to Criticism of the Paper: Critical Reappraisal of Balangero Chrysotile and Mesothelioma Risk by Magnani et Al. ”. 2022. Epidemiology, Biostatistics, and Public Health 12 (3). https://doi.org/10.2427/11448.